These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 16708395

  • 1. Estimation of phospholipophilicity of 1-[3-(arylpiperazin-1-yl)-propyl]-pyrrolidin-2-one derivatives on immobilized artificial membrane stationary phase and its correlation with biological data.
    Kulig K, Malawska B.
    Biomed Chromatogr; 2006 Nov; 20(11):1129-35. PubMed ID: 16708395
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K, Sapa J, Nowaczyk A, Filipek B, Malawska B.
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lipophilicity parameter from high-performance liquid chromatography on an immobilized artificial membrane column and its relationships to bioactivity of the group of 2,4-dihydroxythiobenzanilides.
    Jóźwiak K, Szumiło H, Senczyna B.
    Acta Pol Pharm; 2002 Oct; 59(5):341-6. PubMed ID: 12602794
    [Abstract] [Full Text] [Related]

  • 6. Prediction of drug-membrane interactions by IAM-HPLC: effects of different phospholipid stationary phases on the partition of bases.
    Barbato F, di Martino G, Grumetto L, La Rotonda MI.
    Eur J Pharm Sci; 2004 Jul; 22(4):261-9. PubMed ID: 15196582
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F, Cirocco V, Grumetto L, Immacolata La Rotonda M.
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K, Sapa J, Maciag D, Filipek B, Malawska B.
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [Abstract] [Full Text] [Related]

  • 11. Quantitative structure-retention relationship studies using immobilized artificial membrane chromatography I: amended linear solvation energy relationships with the introduction of a molecular electronic factor.
    Li J, Sun J, Cui S, He Z.
    J Chromatogr A; 2006 Nov 03; 1132(1-2):174-82. PubMed ID: 16919656
    [Abstract] [Full Text] [Related]

  • 12. Can protonated beta-blockers interact with biomembranes stronger than neutral isolipophilic compounds? A chromatographic study on three different phospholipid stationary phases (IAM-HPLC).
    Barbato F, di Martino G, Grumetto L, La Rotonda MI.
    Eur J Pharm Sci; 2005 Nov 03; 25(4-5):379-86. PubMed ID: 15979535
    [Abstract] [Full Text] [Related]

  • 13. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
    Kotecha J, Shah S, Rathod I, Subbaiah G.
    Int J Pharm; 2007 Mar 21; 333(1-2):127-35. PubMed ID: 17095172
    [Abstract] [Full Text] [Related]

  • 14. The effect of stationary phase on lipophilicity determination of beta-blockers using reverse-phase chromatographic systems.
    Welerowicz T, Buszewski B.
    Biomed Chromatogr; 2005 Dec 21; 19(10):725-36. PubMed ID: 15856476
    [Abstract] [Full Text] [Related]

  • 15. Quantitative structure-retention relationship studies with immobilized artificial membrane chromatography II: partial least squares regression.
    Li J, Sun J, He Z.
    J Chromatogr A; 2007 Jan 26; 1140(1-2):174-9. PubMed ID: 17161410
    [Abstract] [Full Text] [Related]

  • 16. Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data.
    Grumetto L, Carpentiero C, Di Vaio P, Frecentese F, Barbato F.
    J Pharm Biomed Anal; 2013 Mar 05; 75():165-72. PubMed ID: 23261809
    [Abstract] [Full Text] [Related]

  • 17. Immobilized artificial membrane chromatography with mass spectrometric detection: a rapid method for screening drug-membrane interactions.
    Liu H, Carter GT, Tischler M.
    Rapid Commun Mass Spectrom; 2001 Mar 05; 15(17):1533-8. PubMed ID: 11544589
    [Abstract] [Full Text] [Related]

  • 18. Chromatographic estimation of drug disposition properties by means of immobilized artificial membranes (IAM) and C18 columns.
    Lázaro E, Ràfols C, Abraham MH, Rosés M.
    J Med Chem; 2006 Aug 10; 49(16):4861-70. PubMed ID: 16884298
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.
    Handzlik J, Maciag D, Kubacka M, Mogilski S, Filipek B, Stadnicka K, Kieć-Kononowicz K.
    Bioorg Med Chem; 2008 Jun 01; 16(11):5982-98. PubMed ID: 18490167
    [Abstract] [Full Text] [Related]

  • 20. Immobilized Artificial Membrane HPLC Derived Parameters vs PAMPA-BBB Data in Estimating in Situ Measured Blood-Brain Barrier Permeation of Drugs.
    Grumetto L, Russo G, Barbato F.
    Mol Pharm; 2016 Aug 01; 13(8):2808-16. PubMed ID: 27377191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.